Speaker illustration

Professor Chern-En Chiang

Taipei Veterans General Hospital, Taipei (Taiwan)

Q&A - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Event: ESC Asia with APSC & AFC 2020

Topic: Chronic Heart Failure

Session: Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb